The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1108
July 9, 2001
View Complete Issue         Table of Contents 2019 
What is Going on with Levothyroxine
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
What is Going on with Levothyroxine
July 9, 2001 (Issue: 1108)
The media recently reported that the FDA has threatened to withdraw Synthroid from the market, alarming many physicians and patients.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: What is Going on with Levothyroxine
Article code: 1108a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.